title: CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.
abstract: β-amyloid (Aβ) plaque accumulation is a hallmark of Alzheimer's disease (AD). It is believed to start many years prior to symptoms and is reflected by reduced cerebrospinal fluid (CSF) levels of the peptide Aβ1-42 (Aβ42). Here we tested the hypothesis that baseline levels of CSF proteins involved in microglia activity, synaptic function and Aβ metabolism predict the development of Aβ plaques, assessed by longitudinal CSF Aβ42 decrease in cognitively healthy people. Forty-six healthy people with three to four serial CSF samples were included (mean follow-up 3 years, range 2-4 years). There was an overall reduction in Aβ42 from a mean concentration of 211-195 pg ml(-1) after 4 years. Linear mixed-effects models using longitudinal Aβ42 as the response variable, and baseline proteins as explanatory variables (n=69 proteins potentially relevant for Aβ metabolism, microglia or synaptic/neuronal function), identified 10 proteins with significant effects on longitudinal Aβ42. The most significant proteins were angiotensin-converting enzyme (ACE, P=0.009), Chromogranin A (CgA, P=0.009) and Axl receptor tyrosine kinase (AXL, P=0.009). Receiver-operating characteristic analysis identified 11 proteins with significant effects on longitudinal Aβ42 (largely overlapping with the proteins identified by linear mixed-effects models). Several proteins (including ACE, CgA and AXL) were associated with Aβ42 reduction only in subjects with normal baseline Aβ42, and not in subjects with reduced baseline Aβ42. We conclude that baseline CSF proteins related to Aβ metabolism, microglia activity or synapses predict longitudinal Aβ42 reduction in cognitively healthy elders. The finding that some proteins only predict Aβ42 reduction in subjects with normal baseline Aβ42 suggest that they predict future development of the brain Aβ pathology at the earliest stages of AD, prior to widespread development of Aβ plaques.
authors: Department of Veterans Affairs Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, CA 94121, USA. niklas.mattsson@neuro.gu.se
authors: N
authors: N
authors: Mattsson
authors: P
authors: P
authors: Insel
authors: R
authors: R
authors: Nosheny
authors: H
authors: H
authors: Zetterberg
authors: J Q
authors: JQ
authors: Trojanowski
authors: L M
authors: LM
authors: Shaw
authors: D
authors: D
authors: Tosun
authors: M
authors: M
authors: Weiner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid* / Q000378:metabolism; D015415:Biomarkers / Q000134:cerebrospinal fluid; D053379:Chromogranin A / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D016014:Linear Models; D008137:Longitudinal Studies; D008297:Male; D017628:Microglia; D010446:Peptide Fragments / Q000134:cerebrospinal fluid* / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000134:cerebrospinal fluid*; D058225:Plaque, Amyloid / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000134:cerebrospinal fluid*; D012372:ROC Curve; D020794:Receptor Protein-Tyrosine Kinases / Q000134:cerebrospinal fluid*; D013569:Synapses; D000094963:Axl Receptor Tyrosine Kinase
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers; D053379:Chromogranin A; D010446:Peptide Fragments; D011518:Proto-Oncogene Proteins; C075222:amyloid beta-protein (1-42); D020794:Receptor Protein-Tyrosine Kinases; D007703:Peptidyl-Dipeptidase A; D000094963:Axl Receptor Tyrosine Kinase; C000722289:AXL protein, human
references: Neurobiol Aging. 2006 Mar;27(3):394-401
references: 16125823
references: Nat Rev Neurol. 2010 Mar;6(3):131-44
references: 20157306
references: Ann Neurol. 2006 Mar;59(3):512-9
references: 16372280
references: Neuromolecular Med. 2011 Jun;13(2):151-9
references: 21567187
references: Neurology. 2012 Aug 28;79(9):897-905
references: 22855860
references: Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):8-16
references: 22354138
references: Biomark Med. 2012 Aug;6(4):455-76
references: 22917147
references: N Engl J Med. 2013 Jan 10;368(2):117-27
references: 23150934
references: Lancet Neurol. 2010 Jan;9(1):119-28
references: 20083042
references: Mol Neurodegener. 2011 Aug 26;6(1):63
references: 21871088
references: Neurobiol Aging. 2008 Aug;29(8):1143-59
references: 17428581
references: Neurobiol Aging. 2012 Aug;33(8):1591-8
references: 21741127
references: Lancet Neurol. 2012 Aug;11(8):669-78
references: 22749065
references: Acta Neuropathol. 2010 Jun;119(6):669-78
references: 20232070
references: Arch Gen Psychiatry. 2012 Jan;69(1):98-106
references: 22213792
references: Arch Neurol. 2003 Dec;60(12):1696-702
references: 14676043
references: Alzheimers Dement. 2011 Jul;7(4):386-395.e6
references: 21784349
references: PLoS One. 2009 Jul 17;4(7):e6294
references: 19609443
references: Arch Neurol. 2011 Oct;68(10):1257-66
references: 21670386
references: Arch Neurol. 2010 Feb;67(2):217-23
references: 20142530
references: Ann Neurol. 2009 Apr;65(4):403-13
references: 19296504
references: Arch Neurol. 2006 Jul;63(7):936-9
references: 16831961
references: J Neural Transm (Vienna). 2011 May;118(5):727-35
references: 21533607
references: Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):73-84
references: 20847637
references: Bioinformatics. 2005 Oct 15;21(20):3940-1
references: 16096348
references: Ann Neurol. 2011 Jan;69(1):181-92
references: 21280088
references: Neurology. 2009 Oct 13;73(15):1193-9
references: 19822868
references: N Engl J Med. 2013 Jan 10;368(2):107-16
references: 23150908
references: N Engl J Med. 2012 Aug 30;367(9):795-804
references: 22784036
references: Neurology. 2011 Jun 14;76(24):2124-5
references: 21562250
references: Neuron. 2005 Dec 22;48(6):913-22
references: 16364896
references: J Alzheimers Dis. 2007 Nov;12(3):255-60
references: 18057559
references: Neurology. 2003 Feb 25;60(4):652-6
references: 12601108
references: PLoS One. 2011 Apr 19;6(4):e18850
references: 21526197